Deep vein thrombosis treatment approach: Difference between revisions
Jump to navigation
Jump to search
Kashish Goel (talk | contribs) No edit summary |
Kashish Goel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
'''Editors-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] '''Associate Editor-In-Chief''': [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]][mailto:urastogi@perfuse.org | '''Editors-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] '''Associate Editor-In-Chief''': [[User:Kashish Goel|Kashish Goel,M.D.]]; [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]][mailto:urastogi@perfuse.org] | ||
{{Deep vein thrombosis}} | {{Deep vein thrombosis}} | ||
==Overview== | ==Overview== |
Revision as of 16:14, 23 May 2012
Editors-in-Chief: C. Michael Gibson, M.S., M.D. Associate Editor-In-Chief: Kashish Goel,M.D.; Ujjwal Rastogi, MBBS[1]
Deep Vein Thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Special Scenario |
Trials |
Case Studies |
Deep vein thrombosis treatment approach On the Web |
Risk calculators and risk factors for Deep vein thrombosis treatment approach |
Overview
The following algorithm describes the treatment approach to DVT[1]:
- Click here for Diagnosis approach.
#Administer parenteral anticoagulants as per ACCP guidelines using the recommended doses.
¶Comorbid conditions may include history of hemorrhagic CVA, recent bleeding episodes, recent surgery or trauma, severe uncontrolled hypertension, renal failure, potential for non-compliance, suspicion of PE or pregnancy.
References
- ↑ Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ (2012). "Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 141 (2 Suppl): 7S–47S. doi:10.1378/chest.1412S3. PMID 22315257. Unknown parameter
|month=
ignored (help)